335 related articles for article (PubMed ID: 23221800)
21. Accumulation of Peptidoglycan O-Acetylation Leads to Altered Cell Wall Biochemistry and Negatively Impacts Pathogenesis Factors of Campylobacter jejuni.
Ha R; Frirdich E; Sychantha D; Biboy J; Taveirne ME; Johnson JG; DiRita VJ; Vollmer W; Clarke AJ; Gaynor EC
J Biol Chem; 2016 Oct; 291(43):22686-22702. PubMed ID: 27474744
[TBL] [Abstract][Full Text] [Related]
22. A novel DNA-binding protein plays an important role in Helicobacter pylori stress tolerance and survival in the host.
Wang G; Maier RJ
J Bacteriol; 2015 Mar; 197(5):973-82. PubMed ID: 25535274
[TBL] [Abstract][Full Text] [Related]
23. Structural analysis of a specialized type III secretion system peptidoglycan-cleaving enzyme.
Burkinshaw BJ; Deng W; Lameignère E; Wasney GA; Zhu H; Worrall LJ; Finlay BB; Strynadka NC
J Biol Chem; 2015 Apr; 290(16):10406-17. PubMed ID: 25678709
[TBL] [Abstract][Full Text] [Related]
24. The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae.
Vollmer W; Tomasz A
J Biol Chem; 2000 Jul; 275(27):20496-501. PubMed ID: 10781617
[TBL] [Abstract][Full Text] [Related]
25. From bacterial killing to immune modulation: Recent insights into the functions of lysozyme.
Ragland SA; Criss AK
PLoS Pathog; 2017 Sep; 13(9):e1006512. PubMed ID: 28934357
[TBL] [Abstract][Full Text] [Related]
26. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity.
Bera A; Biswas R; Herbert S; Götz F
Infect Immun; 2006 Aug; 74(8):4598-604. PubMed ID: 16861647
[TBL] [Abstract][Full Text] [Related]
27. Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance.
Hébert L; Courtin P; Torelli R; Sanguinetti M; Chapot-Chartier MP; Auffray Y; Benachour A
Infect Immun; 2007 Nov; 75(11):5390-8. PubMed ID: 17785473
[TBL] [Abstract][Full Text] [Related]
28. Characterization of O-acetylation of N-acetylglucosamine: a novel structural variation of bacterial peptidoglycan.
Bernard E; Rolain T; Courtin P; Guillot A; Langella P; Hols P; Chapot-Chartier MP
J Biol Chem; 2011 Jul; 286(27):23950-8. PubMed ID: 21586574
[TBL] [Abstract][Full Text] [Related]
29. Tolerance mechanisms of human-residential bifidobacteria against lysozyme.
Sakurai T; Hashikura N; Minami J; Yamada A; Odamaki T; Xiao JZ
Anaerobe; 2017 Oct; 47():104-110. PubMed ID: 28478277
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of the wall-associated de-N-acetylase (PgdA) of Listeria monocytogenes results in greater susceptibility of the cells to induced autolysis.
Popowska M; Kusio M; Szymanska P; Markiewicz Z
J Microbiol Biotechnol; 2009 Sep; 19(9):932-45. PubMed ID: 19809250
[TBL] [Abstract][Full Text] [Related]
31. Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways.
Rae CS; Geissler A; Adamson PC; Portnoy DA
Infect Immun; 2011 Sep; 79(9):3596-606. PubMed ID: 21768286
[TBL] [Abstract][Full Text] [Related]
32. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria.
Callewaert L; Aertsen A; Deckers D; Vanoirbeek KG; Vanderkelen L; Van Herreweghe JM; Masschalck B; Nakimbugwe D; Robben J; Michiels CW
PLoS Pathog; 2008 Mar; 4(3):e1000019. PubMed ID: 18369469
[TBL] [Abstract][Full Text] [Related]
33. SigV Mediates Lysozyme Resistance in Enterococcus faecalis via RsiV and PgdA.
Parthasarathy S; Wang X; Carr KR; Varahan S; Hancock EB; Hancock LE
J Bacteriol; 2021 Sep; 203(20):e0025821. PubMed ID: 34370556
[TBL] [Abstract][Full Text] [Related]
34. Impact of cell wall peptidoglycan O-acetylation on the pathogenesis of Staphylococcus aureus in septic arthritis.
Baranwal G; Mohammad M; Jarneborn A; Reddy BR; Golla A; Chakravarty S; Biswas L; Götz F; Shankarappa S; Jin T; Biswas R
Int J Med Microbiol; 2017 Oct; 307(7):388-397. PubMed ID: 28802679
[TBL] [Abstract][Full Text] [Related]
35. Multiple peptidoglycan modification networks modulate Helicobacter pylori's cell shape, motility, and colonization potential.
Sycuro LK; Wyckoff TJ; Biboy J; Born P; Pincus Z; Vollmer W; Salama NR
PLoS Pathog; 2012; 8(3):e1002603. PubMed ID: 22457625
[TBL] [Abstract][Full Text] [Related]
36. Assay for peptidoglycan O-acetyltransferase: a potential new antibacterial target.
Moynihan PJ; Clarke AJ
Anal Biochem; 2013 Aug; 439(2):73-9. PubMed ID: 23660013
[TBL] [Abstract][Full Text] [Related]
37. Colonize, evade, flourish: how glyco-conjugates promote virulence of Helicobacter pylori.
Rubin EJ; Trent MS
Gut Microbes; 2013; 4(6):439-53. PubMed ID: 23859890
[TBL] [Abstract][Full Text] [Related]
38. The RecRO pathway of DNA recombinational repair in Helicobacter pylori and its role in bacterial survival in the host.
Wang G; Lo LF; Maier RJ
DNA Repair (Amst); 2011 Apr; 10(4):373-9. PubMed ID: 21292567
[TBL] [Abstract][Full Text] [Related]
39. Two lytic transglycosylases in Neisseria gonorrhoeae impart resistance to killing by lysozyme and human neutrophils.
Ragland SA; Schaub RE; Hackett KT; Dillard JP; Criss AK
Cell Microbiol; 2017 Mar; 19(3):. PubMed ID: 27597434
[TBL] [Abstract][Full Text] [Related]
40. Superoxide dismutase-deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization.
Seyler RW; Olson JW; Maier RJ
Infect Immun; 2001 Jun; 69(6):4034-40. PubMed ID: 11349073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
